Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thymoma Type B3”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Study completedNCT04710628
What this trial is testing

Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents

Who this might be right for
Metastatic Thymic CarcinomaThymoma Type B3
MedSIR 43
Testing effectiveness (Phase 2)UnknownNCT03449173
What this trial is testing

Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)

Who this might be right for
Type B3 ThymomaThymic Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 56
Testing effectiveness (Phase 2)Ended earlyNCT01301391
What this trial is testing

Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy

Who this might be right for
Malignant Thymoma
Tiziana Life Sciences LTD 30
Testing effectiveness (Phase 2)UnknownNCT03921671
What this trial is testing

Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)

Who this might be right for
Thymic CarcinomaThymoma
Claudia Proto 60
Testing effectiveness (Phase 2)Ended earlyNCT01011439
What this trial is testing

Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Tiziana Life Sciences LTD 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT03134118
What this trial is testing

Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)

Who this might be right for
Thymoma Type B3Thymic Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC 55
Testing effectiveness (Phase 2)Study completedNCT02307500
What this trial is testing

Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy

Who this might be right for
Pancreas CancerOvarian CancerMelanoma+4 more
Istituto Clinico Humanitas 82